Related Experiment Video
Updated: Jun 12, 2026
07:05
Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents
Published on: September 10, 2018
A stochastic framework for estimation of summary measures in cost-effectiveness analyses
Joseph C Gardiner1, Zhehui Luo, Lin Liu
1Michigan State University, Division of Biostatistics, Department of Epidemiology, B629 West Fee Hall, East Lansing, MI 48823, USA. gardine3@msu.edu.
Expert Review of Pharmacoeconomics & Outcomes Research
|June 10, 2010
Summary
Stochastic modeling using Markov processes helps analyze patient health and costs. This approach aids cost-effectiveness analysis by linking individual characteristics to healthcare intervention outcomes.
Area of Science:
- Health Economics
- Biostatistics
- Medical Decision Making
Background:
- Stochastic modeling is crucial for cost-effectiveness analysis (CEA) in healthcare.
- Understanding patient health and cost outcomes requires identifying influential individual characteristics.
Purpose of the Study:
- To present a stochastic modeling framework for analyzing patient health and cost outcomes.
- To demonstrate its application in cost-effectiveness analysis of healthcare interventions.
Main Methods:
- Utilized a continuous-time finite-state nonhomogeneous Markov process to model patient health states over time.
- Defined health outcomes (e.g., life expectancy, quality-adjusted survival) and costs (resource use, transitions) within the Markov process framework.
- Developed regression models to estimate summary statistics and quantify the impact of explanatory variables on costs and outcomes.
Main Results:
- Established methods to define and calculate key CEA metrics like net health benefit and cost-effectiveness ratio.
- Quantified the influence of individual characteristics on both health and economic outcomes.
- Demonstrated the integration of longitudinal cost and clinical data for comprehensive analysis.
Conclusions:
- The proposed Markov process modeling framework effectively integrates patient health and cost data.
- This approach enhances the analysis of healthcare interventions by providing a dynamic, longitudinal perspective.
- It supports more robust cost-effectiveness analyses by explicitly modeling individual characteristics and their impact.
Related Concept Videos
01:06What are Estimates?
It isn't easy to measure a parameter such as the mean height or the mean weight of a population. So, we draw samples from the population and calculate the mean height or mean weight of the individuals in the sample. This sample data acts as a representative measure of the population parameter. These sample statistics are known as estimates.
The estimate for the mean of a sample is denoted by ͞x, whereas the mean of the population is designated as μ. Further, parameters such as the mean,...
The estimate for the mean of a sample is denoted by ͞x, whereas the mean of the population is designated as μ. Further, parameters such as the mean,...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:25Statistical Methods for Analyzing Epidemiological Data
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
01:23Mechanistic Models: Compartment Models in Individual and Population Analysis
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least squares (OLS)...
01:24Kaplan-Meier Approach
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
01:20Comparing the Survival Analysis of Two or More Groups
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...